openPR Logo
Press release

Dipyridamole Market Key Players And Growth Analysis With Forecast | 2024

12-17-2018 07:39 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Transparency Market Research Reports

/ PR Agency: Transparency Market Research Reports
Dipyridamole Market Key Players And Growth Analysis With

Dipyridamole is a yellow, odorless, and bitter-tasting crystalline powder. Dipyridamole is an oral antiplatelet drug. It is soluble in dilute acids, chloroform, and methanol but does not dissolve in water. Dipyridamole is a drug used in combination with blood thinners such as warfarin or aspirin to prevent the formation of clots after the replacement of the heart valve. Clots are a serious medical complication which could cause heart attacks, strokes, or blocking of blood vessels in the lungs. Dipyridamole is an anti-platelet drug which maintains a constant blood flow by stopping platelets from forming a clump and keeping the blood vessels open. Dipyridamole is used to treat and prevent myocardial reinfarction, blood clots in the brain, obstruction of blood vessels by blood clots, and transient ischemic attacks. Side effects of this drug include dizziness, stomach upsets, diarrhea, vomiting, headaches, and flushing.

For More Industrial Insights Get PDF Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22253

Dipyridamole tablets are platelet inhibitors. Each tablet contains 25 mg, 50 mg, or 75 mg of dipyridamole. Inactive ingredients present in these tablets include colloidal silicon dioxide, hypromellose, lactose monohydrate, polyethylene glycol, sodium starch glycolate, pregelatinized starch, povidone, magnesium stearate, talc, and titanium oxide. Dipyridamole increases the power of prostacyclin by preventing the phosphodiesterase enzyme activity which increases the intracellular cAMP levels. It inhibits the cellular uptake of adenosine which acts on coronary vessels and is used to evaluate coronary artery diseases in patients who cannot exercise satisfactorily and increase the blood flow to their hearts, simulating exercise.

Dipyridamole exhibits several side-effects on reacting with other medicines such as theophylline, adenosine, and anticholinesterases, which may decrease its effectiveness. There are several precautions that need to be followed while consuming the dipyridamole tablet, especially in cases of low blood pressure, drug allergies, while taking aspirin or vitamin doses, and in pregnancy. It could cause severe allergic reactions such as itching, difficulty in breathing, swelling of the mouth, tightness in the chest, swelling of the face, swelling of the lips or tongue, irregular or slow heartbeats, weakness, and chest pain. One of the adverse effect of using dipyridamole is that it increases the risk of bleeding, so in order to stop the bleeding it is taken in combination with aspirin. Dipyridamole tablets should be used cautiously by patients with hypotension as they can produce peripheral vasodilation. Dipyridamole is available on special cases for the patients who have prosthetic heart valves after coronary artery bypass surgery (CABG).

Request for Customization:
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=22253

Key players operating in dipyridamole market are Teva Pharmaceuticals Industries Ltd, Taj Pharmaceuticals Limited, Boehringer Ingelheim Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., and Global Pharmaceuticals.

ABOUT US:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dipyridamole Market Key Players And Growth Analysis With Forecast | 2024 here

News-ID: 1443284 • Views:

More Releases from Transparency Market Research Reports

High Purity Quartz Market - Global Industry Report, 2030
High Purity Quartz Market: Introduction Albany, NY - The global high purity quartz market was valued at ~US$ 800 Mn in 2019 and is anticipated to expand at a CAGR of ~6% during the forecast period. The global high purity quartz market is driven by increase in demand for high purity quartz in the global semiconductor industry. Asia Pacific accounts for a major share of the global high purity quartz market,
Smart Remote Control Market: Analysts Expect Robust Growth in 2028
The rise in the use of technology across the globe has hit the shore of remote controls too. On the back of technological advancements, the smart remote control market may gain considerable momentum across the forecast period of 2019 -2028. The shift in consumer preference from cost-effectiveness to convenience is serving as a prominent growth factor for the smart remote control market. Based on technology type, the smart remote control
HYDROGEN SULFIDE SCAVENGERS MARKET TO REACH A VALUE OF ~US$ 655 MN BY 2027: TRAN …
Hydrogen Sulfide Scavengers Market: Key Highlights The global hydrogen sulfide scavengers market was valued at ~US$ 440 Mn in 2018, and is anticipated to expand at a CAGR of ~5% from 2019 to 2027. Increase in crude oil production enhances oilfield operations such as drilling, cementing, production, workover and completion, and well stimulation. This drives the demand for production chemicals such as hydrogen sulfide scavengers. The demand for crude oil is increasing
METAL-ORGANIC FRAMEWORK MARKET TO REACH A VALUATION OF ~US$ 24 MN BY 2027: TRANS …
Metal-organic Framework Market: Introduction In terms of value, the global metal-organic framework market is anticipated to expand at a CAGR of ~11% from 2019 to 2027 Metal-organic framework is a class of porous materials constructed from metal-rich inorganic nodes bonded with organic linkers. The structure provides high density of three-dimensional porous cores with a large surface area, uniform cross-linkages, and tunable porosity. Metal-organic framework possesses excellent absorption rate for hydrogen, water, carbon

All 5 Releases


More Releases for Dipyridamole

Dipyridamole Injection Market Industry Analysis by Size, Share, Growth, Sourcing …
" The global dipyridamole injection market is valued at approximately $355 million in 2024, driven by increasing demand for antiplatelet therapies and rising awareness of vascular health. The market is projected to reach around $550 million by 2034, reflecting a Compound Annual Growth Rate (CAGR) of approximately 4.5% over the forecast period from 2025 to 2034." Exactitude Consultancy., Ltd. released a research report titled "Dipyridamole Injection Market". This report covers the
Global Antiplatelet Drugs Market by Type (Aspirin, Clopidogrel, Ticagrelor, Pras …
Market Analysis and Size The antiplatelet drugs market was valued at USD 2.05 billion in 2021 and is expected to reach USD 3.82 billion by 2029, registering a CAGR of 8.10% during the forecast period of 2022 to 2032. During the forecast period, it is anticipated that the market for antiplatelet medications will expand quickly. Blood clots can be avoided with the use of antiplatelet drugs, which are occasionally wrongly referred
Dipyridamole Market: In-depth Research on Major Suppliers, Business Standards, T …
A detailed analysis of the Global Dipyridamole Market Growth (Status and Outlook) from 2022 to 2030. In-depth research has been gathered to provide the most recent information on the Dipyridamole market's critical characteristics. The study includes market forecasts for revenue size, production, CAGR, consumption, gross margin, price, and other significant parameters. Key regions that are accelerating marketization are used to split the market study. The report is a great blend
Dipyridamole Market By Manufacturers, Type, Applications, Forecast 2024
Dipyridamole is a yellow, odorless, and bitter-tasting crystalline powder. Dipyridamole is an oral antiplatelet drug. It is soluble in dilute acids, chloroform, and methanol but does not dissolve in water. Dipyridamole is a drug used in combination with blood thinners such as warfarin or aspirin to prevent the formation of clots after the replacement of the heart valve. Clots are a serious medical complication which could cause heart attacks, strokes,
Dipyridamole Market: Growth, Demand, Supply, SWOT, Consumption, ROI to 2024
Global Dipyridamole Market: Overview Dipyridamole is a yellow, odorless, and bitter-tasting crystalline powder. Dipyridamole is an oral antiplatelet drug. It is soluble in dilute acids, chloroform, and methanol but does not dissolve in water. Dipyridamole is a drug used in combination with blood thinners such as warfarin or aspirin to prevent the formation of clots after the replacement of the heart valve. Clots are a serious medical complication which could cause
Dipyridamole Market Evolving Industry Trends 2024
Dipyridamole is a yellow, odorless, and bitter-tasting crystalline powder. Dipyridamole is an oral antiplatelet drug. It is soluble in dilute acids, chloroform, and methanol but does not dissolve in water. Dipyridamole is a drug used in combination with blood thinners such as warfarin or aspirin to prevent the formation of clots after the replacement of the heart valve. Clots are a serious medical complication which could cause heart attacks, strokes,